End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.35 USD | 0.00% | +0.45% | +16.29% |
30/04 | Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals | MT |
30/04 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+16.29% | 377.42Cr | |
+41.79% | 5.09TCr | |
-0.56% | 4.21TCr | |
+49.62% | 4.2TCr | |
-7.20% | 2.92TCr | |
+12.59% | 2.6TCr | |
-21.51% | 1.89TCr | |
+6.92% | 1.32TCr | |
+24.91% | 1.22TCr | |
+29.60% | 1.22TCr |
- Stock Market
- Equities
- ALVO Stock
- News Alvotech
- Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent